These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20047861)

  • 1. Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan.
    Boku N
    Jpn J Clin Oncol; 2010 Mar; 40(3):183-7. PubMed ID: 20047861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Participation to international registration trials--from the investigator's standpoint].
    Ohtsu A
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):297-300. PubMed ID: 17301548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The progress of second-line chemotherapy and molecular targeting agents in gastric cancer].
    Takiuchi H
    Gan To Kagaku Ryoho; 2009 May; 36(5):717-20. PubMed ID: 19461169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful gastrointestinal cancer drug development.
    Hecht JR
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S24-7. PubMed ID: 17178281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of an anticancer drug in Japan based on a new clinical trial system].
    Nakashima H; Nakano S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latest advances in chemotherapy for gastrointestinal cancers.
    Ohtsu A
    Int J Clin Oncol; 2003 Aug; 8(4):234-8. PubMed ID: 12955579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
    Hochster HS; Haller DG; de Gramont A; Berlin JD; Philip PA; Moore MJ; Ajani JA
    Cancer; 2006 Aug; 107(4):676-85. PubMed ID: 16847885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy for the development of novel anticancer drugs.
    Saijo N; Tamura T; Nishio K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development].
    Akaza H; Aiba K; Isonishi S; Ogawa O; Shibuya M; Sone S; Tsuruo T; Noguchi S; Hinotsu S; Kono S; Mikami O; Blackledge G; Vose B; Stribling D
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1681-93. PubMed ID: 11057319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis and its control--lessons from the past and future prospect].
    Shimao T
    Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
    Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
    J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of rapid advancement of international standardization on technical requirements for new drug registration].
    Kurokawa T
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):509-16. PubMed ID: 8678507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New, expanded, and modified use of approved antineoplastic agents in ovarian cancer.
    Markman M
    Oncologist; 2007 Feb; 12(2):186-90. PubMed ID: 17296814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
    Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.